Margaret is the Director of GLP Studies for ResInnova Laboratories. Her scientific background includes a BSc in Biotechnology from Penn State, an MSc in Biotechnology from Johns Hopkins University, and a fellowship at NIH’s National Cancer Institute for Infectious Diseases in Immunocompromised Hosts. Her experience with research & development, laboratory innovation, and federal regulatory compliance helps ResInnova Lab’s clients achieve their product testing goals.